Clinical trials. A pending subject

被引:2
|
作者
Gil-Extremera, B. [1 ]
Jimenez-Lopez, P. [1 ]
Mediavilla-Garcia, J. D. [1 ]
机构
[1] Univ Granada, Dept Med, Granada, Spain
来源
REVISTA CLINICA ESPANOLA | 2018年 / 218卷 / 03期
关键词
Clinical trial; Hypertension; Diabetes; Dyslipidaemia; HIGH-RISK PATIENTS; SYSTOLIC HYPERTENSION; EFFICACY; EVENTS; SAFETY; TELMISARTAN; PREVENTION; DEMENTIA; OUTCOMES; OLDER;
D O I
10.1016/j.rce.2017.06.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clinical trials are essential tools for the progress of clinical medicine in its diagnostic and therapeutic aspects. Since the first trial in 1948, which related tobacco use with lung cancer, there have been more than 150,000 clinical trials to date in various areas (paediatrics, cardiology, oncology, endocrinology, etc.). This article highlights the importance for all physicians to participate, over the course of their professional career, in a clinical trial, due to the inherent benefits for patients, the progress of medicine and for curricular prestige. The authors have created a synthesis of their experience with clinical trials on hypertension, diabetes, dyslipidaemia and ischaemic heart disease over the course of almost 3 decades. Furthermore, a brief reference has been made to the characteristics of a phase I unit, as well as to a number of research studies currently underway. (C) 2017 Elsevier Espana, S.L.U. and Sociedad Espanola de Medicina Interna (SEMI). All rights reserved.
引用
收藏
页码:137 / 141
页数:5
相关论文
共 50 条
  • [41] Fulfillment of the uncertainty principle in cancer clinical trials.
    Joffe, S
    Harrington, DP
    George, SL
    Emanuel, EJ
    Budzinski, L
    Weeks, JC
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 519S - 519S
  • [42] A flexible outcome scoring system for clinical trials.
    Pitman, A. N.
    Pearce, L. B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S87 - S87
  • [43] A prospective patient (pt) survey on clinical trials.
    Moorcraft, Sing Yu
    Marriott, Cheryl
    Peckitt, Clare
    Cunningham, David
    Chau, Ian
    Starling, Naureen
    Watkins, David
    Andreyev, Jervoise
    Rao, Sheela
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [44] Pharmacoeconomic analyses in clinical trials. Principles and practice
    Alvarez, JS
    MEDICINA CLINICA, 2003, 120 (06): : 227 - 235
  • [45] Attitudes of patients towards cancer clinical trials.
    Ayodele, Olubukola
    Akhtar, Mateen
    Eastwood, Mathew Chad
    Linkeviciute-Koneko, Aiste
    Keegan, Niamh M.
    Calacsan, Flordeliza
    O'Connor, Miriam
    Calvert, Paula
    Horgan, Anne M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [46] Factors associated with patient attrition in clinical trials.
    Siddiqi, A.
    Holmes-Rovner, M.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (11) : S230 - S230
  • [47] Monitoring of clinical trials. Establishment, measures and consequences
    Pritsch, M
    Unnebrink, K
    MEDIZINISCHE KLINIK, 1999, 94 (12) : 712 - 717
  • [48] Oncologic patients attitudes and participation in clinical trials.
    Asher, Nethanel
    Wolf, Ido
    Pelles, Sharon
    Geva, Ravit
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] Simulation of clinician prescribing behavior in clinical trials.
    Sale, M
    Ko, H
    Peck, C
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 173 - 173
  • [50] Molecular imaging as a cancer biomarker in clinical trials.
    Mankoff, D.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (02) : 25 - 26